SPARTA Biodiscovery

SPARTA Biodiscovery is a spin-off company from Imperial College London, headquartered in White City, London, developing and commercializing SPARTA® technology. SPARTA® (Single Particle Automated Raman Capture Analysis) is a new analytical platform technology designed to transform the characterization of nanomedicines, such as novel cancer and gene therapies as well as vaccines, through its unique ability to determine the chemical fingerprint of single particles automatically and in a label-free manner. SPARTA® reveals detailed information and characteristics about nanomedicines, such as drug loading, composition, heterogeneity, and stability, addressing unmet needs, accelerating R&D, and improving quality control for this highly promising class of new drugs. SPARTA® will soon be available both as a service and as a benchtop instrument.